Equities researchers at Zacks Research dropped their Q1 2025 EPS estimates for shares of Avanos Medical in a note issued to investors on Wednesday, March 19th. Zacks Research analyst R. Department now ...

Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...

Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

Product Portfolio: Avanos’ robust product suite raises our optimism. Digestive Health is a portfolio of products that includes its MIC-KEY enteral feeding tubes, Corpak patient feeding solutions ...

Avanos Medical has a 52 week low of $14.25 and ... It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient ...

An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

It's my pleasure to welcome you to Avanos 2024 fourth quarter and full ... decision to discontinue certain low-growth, low-margin products. Our overall surgical pain business, while down compared ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

"I am honored to lead such a dynamic organization," stated Pacitti. "Avanos has a strong portfolio of market-leading products and is committed to delivering breakthrough medical device solutions ...

Welcome to the Avanos Fourth Quarter 2024 Earnings Call ... strategic decision to discontinue certain low-growth, low-margin products. Our overall surgical pain business, while down compared ...